Latest molecular experiments have delivered quite a few insights in the processes that govern the event and progression of CLL, which includes several novel mutated genes clustered in different purposeful pathways. The CLL epigenome is reprogrammed from the modulation of regulatory regions that surface de novoRemedy for relapsed/refractory conditio